Mastitis is an inflammation of breast tissue that sometimes involves an infection. The inflammation results in breast pain, swelling, warmth, and redness. Also, have fever and chills. Mastitis most commonly affects women who are breastfeeding (lactation mastitis) The global Mastitis market has been expanding at a stellar pace in recent times.
The increasing cases of breast cancer, the rising rate of pregnancy, and unhygienic barn conditions causing contagious mastitis in bovines across the world is projected to boost the growth of the global Mastitis market. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
On the negative side, the lack of awareness and complications in diagnosis owing to similar symptoms of breast cancer & mastitis are anticipated to limit the growth of the market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Treatment, End User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Bayer AG, Oncothyreon Inc, OncoGenex, Apthera Inc., Zoetis Inc., Boehringer Ingelheim GmbH, Merck Co. & Inc., Astellas Pharma Inc., Pfizer Inc., Novartis AG, Sanofi SA, F. Hoffmann-La Roche AG. |
Covid-19 Impact on Mastitis Market
In addition, the current Mastitis Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Mastitis Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long-term as well as short-term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Mastitis Market Segment Overview
Based on Type, Infectious Mastitis is one of the largest sub-segments in the global Mastitis market. This type of mastitis is usually caused by breast milk staying within the breast tissue. This happens because of a blocked milk duct or a breastfeeding problem. If left untreated, the milk left in the breast tissue can become infected, leading to infectious mastitis. Moreover, By Type, Bovine is another main segment in the global market. Bovidae includes not only cows and oxen but also goats, sheep, bison, and buffalo. So bovine is often used technically when discussing "bovine diseases", "bovine anatomy", and so on.
Mastitis Market, By Type
- Bovine
- Contagious Mastitis
- Environmental Mastitis
- Opportunist Mastitis
- Human
- Non-Infectious Mastitis
- Infectious Mastitis
- Bovine
- Antibiotics
- Vaccines
- Human
- Pain Relievers
- Antibiotics
· Veterinary Centers
· Hospital & Clinics
Mastitis Regional Overview
Geographically, North America is anticipated to dominate the market, primarily due to the growing incidence of mastitis among the bovine population and the growing incidence of breast cancer in the region. Furthermore, Europe is another major region for the market. Advanced treatment facilities, expanding government measures to promote healthy breastfeeding, and rising healthcare expenditures are driving market expansion in this region. Furthermore, Asia-Pacific is expected to be the fastest-growing region in the global market due to the presence of quickly rising economies such as China, India, and South Korea. Furthermore, the market's expansion will be aided by a large number of chronic disease patients and government healthcare reform initiatives.
Mastitis Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Mastitis Market, Key Players
· Bayer AG
· Oncothyreon Inc
· OncoGenex
· Apthera Inc.
· Zoetis Inc.
· Boehringer Ingelheim GmbH
· Merck Co. & Inc.
· Astellas Pharma Inc.
· Pfizer Inc.
· Novartis AG
· Sanofi SA
· F. Hoffmann-La Roche AG
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Mastitis market?
Q2. What are the restraining factors for the global Mastitis market?
Q3. Which segment is projected to hold the largest share in the global Mastitis market?
Q4. Which region holds the largest share in the global Mastitis market?
Q5. Which are the prominent players in the global Mastitis market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Mastitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Bovine
- 5.2.1.1. Contagious Mastitis
- 5.2.1.2. Environmental Mastitis
- 5.2.1.3. Opportunist Mastitis
- 5.2.2. Human
- 5.2.2.1. Non-Infectious Mastitis
- 5.2.2.2. Infectious Mastitis
- 5.2.1. Bovine
- 5.3.1. Bovine
- 5.3.1.1. Antibiotics
- 5.3.1.2. Vaccines
- 5.3.2. Human
- 5.3.2.1. Pain Relievers
- 5.3.2.2. Antibiotics
- 5.4.1. Veterinary Centers
- 5.4.2. Hospital & Clinics
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Mastitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Bovine
- 6.2.1.1. Contagious Mastitis
- 6.2.1.2. Environmental Mastitis
- 6.2.1.3. Opportunist Mastitis
- 6.2.2. Human
- 6.2.2.1. Non-Infectious Mastitis
- 6.2.2.2. Infectious Mastitis
- 6.2.1. Bovine
- 6.3.1. Bovine
- 6.3.1.1. Antibiotics
- 6.3.1.2. Vaccines
- 6.3.2. Human
- 6.3.2.1. Pain Relievers
- 6.3.2.2. Antibiotics
- 6.4.1. Veterinary Centers
- 6.4.2. Hospital & Clinics
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Mastitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Bovine
- 7.2.1.1. Contagious Mastitis
- 7.2.1.2. Environmental Mastitis
- 7.2.1.3. Opportunist Mastitis
- 7.2.2. Human
- 7.2.2.1. Non-Infectious Mastitis
- 7.2.2.2. Infectious Mastitis
- 7.2.1. Bovine
- 7.3.1. Bovine
- 7.3.1.1. Antibiotics
- 7.3.1.2. Vaccines
- 7.3.2. Human
- 7.3.2.1. Pain Relievers
- 7.3.2.2. Antibiotics
- 7.4.1. Veterinary Centers
- 7.4.2. Hospital & Clinics
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Mastitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Bovine
- 8.2.1.1. Contagious Mastitis
- 8.2.1.2. Environmental Mastitis
- 8.2.1.3. Opportunist Mastitis
- 8.2.2. Human
- 8.2.2.1. Non-Infectious Mastitis
- 8.2.2.2. Infectious Mastitis
- 8.2.1. Bovine
- 8.3.1. Bovine
- 8.3.1.1. Antibiotics
- 8.3.1.2. Vaccines
- 8.3.2. Human
- 8.3.2.1. Pain Relievers
- 8.3.2.2. Antibiotics
- 8.4.1. Veterinary Centers
- 8.4.2. Hospital & Clinics
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Mastitis Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Bovine
- 9.2.1.1. Contagious Mastitis
- 9.2.1.2. Environmental Mastitis
- 9.2.1.3. Opportunist Mastitis
- 9.2.2. Human
- 9.2.2.1. Non-Infectious Mastitis
- 9.2.2.2. Infectious Mastitis
- 9.2.1. Bovine
- 9.3.1. Bovine
- 9.3.1.1. Antibiotics
- 9.3.1.2. Vaccines
- 9.3.2. Human
- 9.3.2.1. Pain Relievers
- 9.3.2.2. Antibiotics
- 9.4.1. Veterinary Centers
- 9.4.2. Hospital & Clinics
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Bayer AG
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Oncothyreon Inc
- 10.6. OncoGenex
- 10.7. Apthera Inc.
- 10.8. Zoetis Inc.
- 10.9. Boehringer Ingelheim GmbH
- 10.10. Merck Co. & Inc.
- 10.11. Astellas Pharma Inc.
- 10.12. Pfizer Inc.
- 10.13. Novartis AG
- 10.14. Sanofi SA
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
